title: Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group.
abstract: Adherence to therapy is a key issue in chronic illnesses. In addition, several features of multiple sclerosis (MS) and its treatment may increase the likelihood of patient nonadherence and discontinuation of treatment. Nonadherence will obviously compromise the efficacy of disease-modifying drugs in patients with MS. This subject was discussed by a group of local MS specialists from the Middle East. The group debated several key questions about the features and causes of patient nonadherence and its management. Further, they made recommendations for optimizing treatment adherence in this area.
authors.affiliation: Internal Medicine, American University of Beirut, Beirut, Lebanon. yamoutba@idm.net.lb
authors.forename: Bassem I
authors.initials: BI
authors.lastname: Yamout
authors.forename: Maurice
authors.initials: M
authors.lastname: Dahdaleh
authors.forename: Mohammed Ali
authors.initials: MA
authors.lastname: Al Jumah
authors.forename: Suhail
authors.initials: S
authors.lastname: Al-Shammri
authors.forename: Isa
authors.initials: I
authors.lastname: Al Sharoqi
authors.forename: Abdel Rahman
authors.initials: AR
authors.lastname: Al-Tahan
authors.forename: Saeed
authors.initials: S
authors.lastname: Bohlega
authors.forename: Dirk
authors.initials: D
authors.lastname: Deleu
authors.forename: Jihad
authors.initials: J
authors.lastname: Inshasi
authors.forename: Ahmad
authors.initials: A
authors.lastname: Khalifa
authors.forename: Miklos
authors.initials: M
authors.lastname: Szólics
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D032921:Consensus; D004185:Disability Evaluation; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008877:Middle East / Q000453:epidemiology; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000523:psychology*; D010349:Patient Compliance / Q000706:statistics & numerical data; D017410:Practice Guidelines as Topic; D012720:Severity of Illness Index
chemical_list: D000276:Adjuvants, Immunologic; D007155:Immunologic Factors